SL
BMY icon

Summitry LLC’s Bristol-Myers Squibb BMY Stock Holding History

Summitry LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$492K Buy
8,531
+957
+13% +$55K 0.02% 159
2026
Q1 		$459K Buy
7,574
+954
+14% +$55.6K 0.02% 145
2025
Q4 		$357K Buy
6,620
+1,231
+23% +$59.2K 0.01% 151
2025
Q3 		$243K Sell
5,389
-2,504
-32% -$117K 0.01% 176
2025
Q2 		$365K Buy
+7,893
New +$387K 0.02% 117
2025
Q1 		– Sell
-3,660
Closed -$207K – 147
2024
Q4 		$207K Buy
+3,660
New +$204K 0.01% 131
2023
Q2 		– Sell
-2,904
Closed -$201K – 90
2023
Q1 		$201K Sell
2,904
-262
-8% -$18.5K 0.01% 87
2022
Q4 		$228K Sell
3,166
-136
-4% -$10.3K 0.02% 89
2022
Q3 		$235K Buy
+3,302
New +$240K 0.02% 87
2016
Q4 		– Sell
-3,730
Closed -$201K – 80
2016
Q3 		$201K Hold
3,730
– – 0.02% 83
2016
Q2 		$274K Sell
3,730
-400
-10% -$28.3K 0.03% 75
2016
Q1 		$264K Buy
4,130
+400
+11% +$25.2K 0.03% 75
2015
Q4 		$257K Hold
3,730
– – 0.03% 71
2015
Q3 		$221K Hold
3,730
– – 0.03% 66
2015
Q2 		$248K Sell
3,730
-570
-13% -$37.6K 0.03% 61
2015
Q1 		$277K Hold
4,300
– – 0.03% 57
2014
Q4 		$254K Sell
4,300
-349
-8% -$19.7K 0.03% 60
2014
Q3 		$238K Buy
4,649
+349
+8% +$17.4K 0.03% 60
2014
Q2 		$209K Sell
4,300
-200
-4% -$9.86K 0.03% 65
2014
Q1 		$234K Sell
4,500
-145
-3% -$7.72K 0.03% 63
2013
Q4 		$247K Sell
4,645
-89
-2% -$4.53K 0.03% 68
2013
Q3 		$219K Sell
4,734
-566
-11% -$24.8K 0.03% 64
2013
Q2 		$237K Buy
+5,300
New +$230K 0.04% 61

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Summitry LLC's BMY Position: Q2 2026 in Review

Summitry LLC increased its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, buying an estimated $55K and bringing the position to 8,531 shares worth $492K. The position accounts for 0.02% of the portfolio, ranked #159.

Summitry LLC first reported a position in BMY in Q2 2013 and has held it in 23 quarters since. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Summitry LLC held 8,531 shares of Bristol-Myers Squibb worth $492K as of Q2 2026.
  • Summitry LLC bought 957 Bristol-Myers Squibb shares in Q2 2026, an estimated $55K.
  • Bristol-Myers Squibb made up 0.02% of Summitry LLC's portfolio in Q2 2026, its #159 holding.
  • Summitry LLC first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 23 quarters since.
  • 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Summitry LLC's 13F filing for Q2 2026, filed 21 Jul 2026.